Schutt M - Search Results

1

Simvastatin acutely reduces myocardial reperfusion injury in vivo by activating the phosphatidylinositide 3-kinase/Akt pathway.

Wolfrum S, Dendorfer A, Schutt M, Weidtmann B, Heep A, Tempel K, Klein HH, Dominiak P, Richardt G. Wolfrum S, et al. Among authors: schutt m. J Cardiovasc Pharmacol. 2004 Sep;44(3):348-55. doi: 10.1097/01.fjc.0000137162.14735.30. J Cardiovasc Pharmacol. 2004. PMID: 15475833

2

Calpain inhibition impairs glycogen syntheses in HepG2 hepatoma cells without altering insulin signaling.

Meier M, Klein HH, Kramer J, Drenckhan M, Schütt M. Meier M, et al. Among authors: schutt m. J Endocrinol. 2007 Apr;193(1):45-51. doi: 10.1677/joe.1.07087. J Endocrinol. 2007. PMID: 17400802

3

[New differential therapy of type 2 diabetes].

Schütt M, Klein HH. Schütt M, et al. Internist (Berl). 2011 Apr;52(4):395-6, 398-404. doi: 10.1007/s00108-010-2708-0. Internist (Berl). 2011. PMID: 21424146 Review. German.

4

[The HIV protease inhibitor-induced insulin resistance syndrome].

Schütt M, Meier M, Klein HH. Schütt M, et al. Med Klin (Munich). 2003 Apr 25;98(5):271-6. doi: 10.1007/s00063-003-1256-y. Med Klin (Munich). 2003. PMID: 12721672 Review. German.

5

Long-term effects of HIV-1 protease inhibitors on insulin secretion and insulin signaling in INS-1 beta cells.

Schütt M, Zhou J, Meier M, Klein HH. Schütt M, et al. J Endocrinol. 2004 Dec;183(3):445-54. doi: 10.1677/joe.1.05620. J Endocrinol. 2004. PMID: 15590971

6

Functional characteristics of insulin receptors with a Thr-->Ser1200 mutation overexpressed in Chinese hamster ovary cells.

Schütt M, Benecke H, Drenckhan M, Klein HH. Schütt M, et al. Eur J Endocrinol. 2000 Jul;143(1):125-31. doi: 10.1530/eje.0.1430125. Eur J Endocrinol. 2000. PMID: 10870041

7

Insulin activation of insulin receptor kinase in erythrocytes is not altered in non-insulin-dependent diabetes and not influenced by hyperglycemia.

Klein HH, Müller R, Drenckhan M, Schütt M, Bätge B, Fehm HL. Klein HH, et al. Among authors: schutt m. J Endocrinol. 2000 Aug;166(2):275-81. doi: 10.1677/joe.0.1660275. J Endocrinol. 2000. PMID: 10927617

8

The HIV-1 protease inhibitor indinavir impairs insulin signalling in HepG2 hepatoma cells.

Schütt M, Meier M, Meyer M, Klein J, Aries SP, Klein HH. Schütt M, et al. Diabetologia. 2000 Sep;43(9):1145-8. doi: 10.1007/s001250051505. Diabetologia. 2000. PMID: 11043860

9

The HIV protease inhibitor indinavir impairs glycogen synthesis in HepG2 hepatoma cells.

Schütt M, Meier M, Jost MM, Klein HH. Schütt M, et al. Exp Clin Endocrinol Diabetes. 2003 Feb;111(1):16-20. doi: 10.1055/s-2003-37495. Exp Clin Endocrinol Diabetes. 2003. PMID: 12605345

10

Coexistence of factor V Leiden and primary antiphospholipid syndrome: a patient with recurrent myocardial infarctions and thrombocytopenia.

Schütt M, Klüter H, Wiedemann GJ, Richardt G. Schütt M, et al. Z Kardiol. 2000 Dec;89(12):1067-71. doi: 10.1007/s003920070133. Z Kardiol. 2000. PMID: 11201021

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters